A recent breakthrough in reproductive medicine reported by the Daily Mail discovered a chemical signal that can predict which embryos are more likely to implant in the womb. The findings showed that embryos that gave off trypsin, a chemical that prepares the womb prior to implantation, had a higher rate of acceptance for implantation. The article states that “at present, there are only basic measures available to predict the chances of a patient having a successful pregnancy. These include the patient's age, medical and genetic history and existing statistics on the percentage of IVF cycles which succeed.”
It is exciting that scientists have discovered a chemical signal associated with higher fertility success rates. But the ability to predict IVF success for individual patients has also advanced beyond the “basic measures” mentioned by the Daily Mail article.
A woman’s age has long been the major deciding factor of her fertility. But it is not the only one to consider. Multiple, complex factors determine fertility and a woman’s chance of IVF success, depending on her unique medical profile and that of her partner. Univfy IVF Prediction Tests take into account these factors, which include but are not limited to a woman’s ovarian reserve, a diagnosis of Polycystic Ovarian Syndrome (PCOS), endometriosis, uterine fibroids or unexplained fertility, and her partner’s sperm count, motility or morphology, and use these to provide a highly accurate prediction of her and her partner’s chance of having a baby with IVF.
Nick Macklon, professor of obstetrics and gynecology at the University of Southampton stated in the article “only about one third of the top-quality embryos are implanting, which means there’s a lot of room for improvement.” This new discovery can enhance fertility, and that is the major goal for all fertility specialists.
In turn, advances in IVF prediction technology can also help patients achieve their family-building goals. By taking factors beyond basic measures, Univfy IVF Prediction Tests provide patients with their personalized chance of IVF success. Armed with that information, patients can make more confident decisions about their treatment and family-building options in a way that has never been available before.
To read the article on the Daily Mail, please click here
*If this article interested you, you may enjoy reading Univfy guest blogger Dr. Ronald Feinberg‘s post on pre-implantation genetic screening (PGS) and how testing embryo chromosome health prior to implantation can also enhance implantation rates. Dr. Feinberg is the IVF Medical Director at the Reproductive Associates of Delaware.
Visit Failed IVF for more fertility health information and interactive tools to personalize your fertility path.